Instrument Inactif

Communiqués Vapotherm, Inc.

Actions

VAPO

US9221073052

Equipement et technologie médicale avancés

Communiqués

20/09/24	Vapotherm Announces Closing of Merger	PR
29/08/24	VAPOTHERM INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Vapotherm, Inc. - VAPO	BU
12/08/24	Vapotherm: Q2 Earnings Snapshot	AQ
12/08/24	Vapotherm Reports Second Quarter 2024 Financial Results	PR
01/07/24	Kuehn Law Encourages INFN, RPHM, VAPO, and PRFT Investors to Contact Law Firm	PR
20/06/24	VAPOTHERM INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Vapotherm, Inc. - VAPO	BU
18/06/24	Vapotherm Enters Into Definitive Merger Agreement, Transaction Would Result In Company Going Private	AQ
17/06/24	Vapotherm Enters Into Definitive Merger Agreement; Transaction Would Result In Company Going Private	PR
09/05/24	Vapotherm: Q1 Earnings Snapshot	AQ
09/05/24	Vapotherm Reports First Quarter 2024 Financial Results	PR
20/03/24	Vapotherm : Onymos and Vapotherm Announce Partnership to Create an End-to-End Internet of Medical Things Solution (IoMT)	PU
07/03/24	Vapotherm, Inc. - Dr. David Yamane was awarded the Star Research Award at the 2024 Critical Care Congress for the presentation of the HYPERACT Study	AQ
22/02/24	Vapotherm: Q4 Earnings Snapshot	AQ
22/02/24	Vapotherm Reports Fourth Quarter and Fiscal Year 2023 Financial Results	PR
19/12/23	Vapotherm : Overview	PU
15/12/23	Vapotherm Announces Suspension of NYSE Listing Common Stock Expected to Begin Trading Promptly on OTCQX	PR
11/12/23	Vapotherm Announces Notification to New York Stock Exchange of Intention to Voluntarily Delist Common Stock Application Pending to Transfer Shares to OTCQX	PR
29/11/23	Vapotherm Educates over 8,000 Clinicians in Respiratory Care Month	AQ
09/11/23	Vapotherm Reports Third Quarter 2023 Financial Results	AQ
08/11/23	Vapotherm: Q3 Earnings Snapshot	AQ
11/10/23	Vapotherm : Overview	PU
05/10/23	Computational Fluid Dynamics modeling further distinguishes Vapotherm High Velocity Therapy from generic high flow cannulas	AQ
04/10/23	Computational Fluid Dynamics (CFD) modeling further distinguishes Vapotherm High Velocity Therapy from generic high flow cannulas	BU
25/09/23	Pilot Study demonstrates Vapotherm HVNI technology is more effective than standard oxygen therapy for treatment of acute asthma in children	BU
09/08/23	Vapotherm: Q2 Earnings Snapshot	AQ